A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to lingering symptoms. In Germany, Long COVID develops in up to about one in ten ...

COVID-19 was never just a hit-and-run infection, and the latest science shows why. Even after the active virus is gone, fragments of its genetic material and spike proteins can linger, assemble into ...

How long COVID develops is still largely unknown. New molecular connections are revealed in a recent study led by the Center ...

A schematic diagram showing the significant contribution of SCoV2-induced altered mitochondrial dynamics and mitochondrial EGFR translocation in sustaining viral propagation. First, SCOV2 RNA and ...

During an infection, viruses take over cells and produce more viral particles, which can infect more cells and drive the illness. Scientists have been searching for new COVID-19 treatments that can ...

A study into the long-term health impacts of coronavirus, led by experts from the University of Leicester, Imperial College ...

Scientists at the University of California, Berkeley, have created a new COVID-19 therapeutic that could one day make treating SARS-CoV-2 infections as easy as using a nasal spray for allergies. The ...

A recent iScience study finds that the swine acute diarrhea syndrome coronavirus (SADS-CoV) promotes autophagy to maintain its replication inside host cells. More specifically, the virus downregulates ...

'Zombie' coronavirus fragments not only help drive inflammation in long-COVID, but also destroy our immune cells. A recent study by an international team of more than 30 authors reveals how the ...